|
Wiers, K M; Lathers, D M; Wright, M A et al. (2000) Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy. J Immunother 23:115-24
|
|
Pandit, R; Lathers, D M; Beal, N M et al. (2000) CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer. Ann Otol Rhinol Laryngol 109:749-54
|
|
Lathers, D M; Lubbers, E; Wright, M A et al. (1999) Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients. J Leukoc Biol 65:623-8
|
|
Gabel, S; Benefield, J; Meisinger, J et al. (1999) Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngol Head Neck Surg 121:463-8
|
|
Young, M R; Lathers, D M (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21:241-52
|
|
Lathers, D M; Lubbers, E; Beal, N M et al. (1999) Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different. Hum Immunol 60:1207-15
|
|
Wright, M A; Wiers, K; Vellody, K et al. (1998) Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors. Cancer Immunol Immunother 46:253-60
|
|
Wiers, K; Wright, M A; Vellody, K et al. (1998) Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels. Clin Exp Metastasis 16:275-82
|
|
Meisinger, J; Patel, S; Vellody, K et al. (1997) Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells. Cancer Lett 111:87-95
|
|
Young, M R; Wright, M A; Pandit, R (1997) Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas. J Immunol 159:990-6
|
Showing the most recent 10 out of 50 publications
